FY2025 Earnings Forecast for UNH Issued By Cantor Fitzgerald

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Analysts at Cantor Fitzgerald dropped their FY2025 earnings estimates for UnitedHealth Group in a report released on Wednesday, May 14th. Cantor Fitzgerald analyst S. James now anticipates that the healthcare conglomerate will earn $23.01 per share for the year, down from their prior forecast of $26.27. Cantor Fitzgerald currently has a "Overweight" rating and a $700.00 target price on the stock. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share.

A number of other equities research analysts have also recently commented on the stock. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their target price for the company from $560.00 to $350.00 in a research report on Wednesday. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday. JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday. Six equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $508.38.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $273.96 on Friday. The company's fifty day moving average price is $474.72 and its 200 day moving average price is $515.82. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a market capitalization of $248.52 billion, a PE ratio of 17.67, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same period last year, the company posted $6.91 earnings per share.

Hedge Funds Weigh In On UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in UNH. Estuary Capital Management LP bought a new stake in UnitedHealth Group in the first quarter valued at $49,913,000. Cinctive Capital Management LP raised its stake in shares of UnitedHealth Group by 17.8% during the first quarter. Cinctive Capital Management LP now owns 10,514 shares of the healthcare conglomerate's stock valued at $5,507,000 after purchasing an additional 1,589 shares in the last quarter. Clark Capital Management Group Inc. raised its stake in shares of UnitedHealth Group by 4.3% during the first quarter. Clark Capital Management Group Inc. now owns 233,740 shares of the healthcare conglomerate's stock valued at $122,421,000 after purchasing an additional 9,533 shares in the last quarter. Banque Transatlantique SA raised its stake in shares of UnitedHealth Group by 16.6% during the first quarter. Banque Transatlantique SA now owns 2,905 shares of the healthcare conglomerate's stock valued at $1,406,000 after purchasing an additional 414 shares in the last quarter. Finally, AQR Capital Management LLC raised its position in UnitedHealth Group by 251.5% in the first quarter. AQR Capital Management LLC now owns 784,689 shares of the healthcare conglomerate's stock worth $410,981,000 after acquiring an additional 561,451 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.